Join
Live feed
·
INSIDERFilingvia Quantisnow
Veradermics Incorporated logo

Chief R&D Officer Hollander David was granted 9,650 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MANE· Veradermics Incorporated
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MANE (Veradermics Incorporated) and more on Quantisnow.